Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01188668 · ClinicalTrials.gov registry record · Phase 4
Open Label Drug Interaction Study Evaluating Desvenlafaxine Succinate Sustained Release (DVS SR) 100mg On The Pharmacokinetics Of Aripiprazole When Coadministered To Healthy Subjects
A Phase 4 study of Pharmacokinetics and Cytochrome P-450 CYP2D6, sponsored by Pfizer.
- Completed
- Registry status
- Phase 4
- Development phase
- 38
- Enrollment target
- 2
- Study locations
NCT01188668 is a Phase 4 study of Pharmacokinetics and Cytochrome P-450 CYP2D6 that has completed, run by Pfizer. The registered enrollment target is 38 participants, below the 61-participant average among 37 other Pharmacokinetics trials with a reported enrollment target (38% lower). The trial reports 2 study locations across 1 state.
The verdict
NCT01188668, a Phase 4 study of Pharmacokinetics and Cytochrome P-450 CYP2D6, has completed, sponsored by Pfizer.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 38 participants
- Enrollment target
- 2
- Study locations
Study Summary
The goal of this study is to evaluate the effect of multiple doses of Desvenlafaxine Sustained Release (SR) on the pharmacokinetics of Aripiprazole when coadministered to healthy adult subjects. This study will also evaluate the safety and tolerability of Desvenlafaxine SR and Aripiprazole when coadministered to healthy adult subjects.
Conditions Studied
Interventions
- DRUG Aripiprazole
- DRUG Aripiprazole + desvenlafaxine succinate sustained release
Study Locations (2)
Florida
- Pfizer Investigational Site - Miami
- Pfizer Investigational Site - Miami
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 38 participants |
| Start Date | 2010-08 |
| Est. Completion | 2010-10 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01188668
The ClinicalTrials.gov registry entry for NCT01188668 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 38 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 61-participant average among 37 other Pharmacokinetics trials with a reported enrollment target (38% lower). The listed sponsor is Pfizer, which has 1,845 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Pharmacokinetics appearing as the primary indexed condition, and to 2 interventions - of which Aripiprazole is the first listed.
NCT01188668 reports 2 study locations spanning 1 distinct geographic area - top geographies include Florida.
Frequently Asked Questions
What is clinical trial NCT01188668 about?
NCT01188668 is a clinical study titled "Open Label Drug Interaction Study Evaluating Desvenlafaxine Succinate Sustained Release (DVS SR) 100mg On The Pharmacokinetics Of Aripiprazole When Coadministered To Healthy Subjects". The goal of this study is to evaluate the effect of multiple doses of Desvenlafaxine Sustained Release (SR) on the pharmacokinetics of Aripiprazole when coadministered to healthy adult subjects. This study will also evaluate the safety and tolerability of Desvenlafaxine SR and Aripiprazole when coad...
What is the current status of trial NCT01188668?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 38 participants. The study started on 2010-08. Estimated completion is 2010-10.
What conditions does trial NCT01188668 study?
This clinical trial studies the following conditions: Pharmacokinetics, Cytochrome P-450 CYP2D6, CYP3A4 Protein, Human.
What interventions are being tested in trial NCT01188668?
The interventions under investigation include: Aripiprazole (DRUG), Aripiprazole + desvenlafaxine succinate sustained release (DRUG).
Who is sponsoring clinical trial NCT01188668?
This trial is sponsored by Pfizer, which has 1,845 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01188668 being conducted?
This trial has 2 study locations across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Pharmacokinetics
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Liposomal Bupivacaine Versus Plain Bupivacaine After Intercostal Injections For Pain Management After Thoracoscopy
RECRUITING · Phase 4
-
Study of Drug Exposure in Systemic Circulation of Primatene Mist by Oral Inhalation, Versus Epinephrine Injection by Intramuscular Injection and ProAir by Oral Inhalation in Healthy Individuals
COMPLETED · Phase 4
-
Pharmacokinetics of Aqueous Dexamethasone
COMPLETED · Phase 4
-
Healthy and Renal Impairment Study of Colcrys (Colchicine, USP)
COMPLETED · Phase 4
-
Phase1/2a Study for IPG7236 in Patients With Advanced Solid Tumors
RECRUITING · Phase 1
-
High Potency Cannabis: Acute and Protracted Effects
RECRUITING · Phase 1
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.